ID   DYH9_HUMAN              Reviewed;        4486 AA.
AC   Q9NYC9; A2VCQ8; O15064; O95494; Q9NQ28;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   28-JUN-2023, entry version 179.
DE   RecName: Full=Dynein axonemal heavy chain 9 {ECO:0000305};
DE   AltName: Full=Axonemal beta dynein heavy chain 9;
DE   AltName: Full=Ciliary dynein heavy chain 9;
GN   Name=DNAH9 {ECO:0000312|HGNC:HGNC:2953};
GN   Synonyms=DNAH17L, DNEL1, KIAA0357;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ARG-445 AND ILE-4374.
RA   Reed W., Moats-Staats B.M., Carson J.L., Leigh M.W., Collier A.M.;
RT   "A ciliary dynein heavy chain whose expression is upregulated in
RT   differentiating airway epithelium.";
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-445.
RC   TISSUE=Nasal epithelium;
RX   PubMed=11247663; DOI=10.1006/geno.2000.6462;
RA   Bartoloni L., Blouin J.-L., Maiti A.K., Sainsbury A., Rossier C.,
RA   Gehrig C., She J.X., Marron M.P., Lander E.S., Meeks M., Chung E.M.K.,
RA   Armengot M., Jorissen M., Scott H.S., Delozier-Blanchet C.D.,
RA   Gardiner R.M., Antonarakis S.E.;
RT   "Axonemal beta heavy chain dynein DNAH9: cDNA sequence, genomic structure,
RT   and investigation of its role in primary ciliary dyskinesia.";
RL   Genomics 72:21-33(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1419-4486 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [6]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R., Yamakawa H., Nomura N.;
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1874-1974 (ISOFORM 1).
RC   TISSUE=Nasal polyp;
RA   Maiti A.K., Mattei M.-G., Jorissen M., Volz A., Ziegler A., Bouvagnet P.;
RT   "Chromosomal localization of human dynein heavy chain genes.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   CHARACTERIZATION.
RX   PubMed=11104725; DOI=10.1165/ajrcmb.23.6.4045;
RA   Reed W., Carson J.L., Moats-Staats B.M., Lucier T., Hu P.C., Brighton L.,
RA   Gambling T.M., Huang C.H., Leigh M.W., Collier A.M.;
RT   "Characterization of an axonemal dynein heavy chain expressed early in
RT   airway epithelial ciliogenesis.";
RL   Am. J. Respir. Cell Mol. Biol. 23:734-741(2000).
RN   [9]
RP   FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INVOLVEMENT IN CILD40,
RP   VARIANTS CILD40 GLU-1881; HIS-2965; LEU-3398 AND ASN-4123, AND
RP   CHARACTERIZATION OF VARIANTS CILD40 GLU-1881; HIS-2965 AND ASN-4123.
RX   PubMed=30471717; DOI=10.1016/j.ajhg.2018.10.016;
RA   Fassad M.R., Shoemark A., Legendre M., Hirst R.A., Koll F., le Borgne P.,
RA   Louis B., Daudvohra F., Patel M.P., Thomas L., Dixon M., Burgoyne T.,
RA   Hayes J., Nicholson A.G., Cullup T., Jenkins L., Carr S.B., Aurora P.,
RA   Lemullois M., Aubusson-Fleury A., Papon J.F., O'Callaghan C., Amselem S.,
RA   Hogg C., Escudier E., Tassin A.M., Mitchison H.M.;
RT   "Mutations in outer dynein arm heavy chain DNAH9 cause motile cilia defects
RT   and situs inversus.";
RL   Am. J. Hum. Genet. 103:984-994(2018).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH ODAD1, INVOLVEMENT IN
RP   CILD40, VARIANTS CILD40 666-TRP--ILE-4486 DEL; ARG-1674; 2751-GLN--ILE-4486
RP   DEL AND 3889-SER--ILE-4486 DEL, AND CHARACTERIZATION OF VARIANT CILD40
RP   2751-GLN--ILE-4486 DEL.
RX   PubMed=30471718; DOI=10.1016/j.ajhg.2018.10.020;
RA   Loges N.T., Antony D., Maver A., Deardorff M.A., Guelec E.Y., Gezdirici A.,
RA   Noethe-Menchen T., Hoeben I.M., Jelten L., Frank D., Werner C., Tebbe J.,
RA   Wu K., Goldmuntz E., Cuturilo G., Krock B., Ritter A., Hjeij R., Bakey Z.,
RA   Pennekamp P., Dworniczak B., Brunner H., Peterlin B., Tanidir C.,
RA   Olbrich H., Omran H., Schmidts M.;
RT   "Recessive DNAH9 loss-of-function mutations cause laterality defects and
RT   subtle respiratory ciliary-beating defects.";
RL   Am. J. Hum. Genet. 103:995-1008(2018).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-771; HIS-2653 AND ASN-3664.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [12]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=31178125; DOI=10.1016/j.ajhg.2019.04.015;
RA   Whitfield M., Thomas L., Bequignon E., Schmitt A., Stouvenel L.,
RA   Montantin G., Tissier S., Duquesnoy P., Copin B., Chantot S., Dastot F.,
RA   Faucon C., Barbotin A.L., Loyens A., Siffroi J.P., Papon J.F., Escudier E.,
RA   Amselem S., Mitchell V., Toure A., Legendre M.;
RT   "Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm
RT   Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.";
RL   Am. J. Hum. Genet. 105:198-212(2019).
CC   -!- FUNCTION: Force generating protein required for cilia beating in
CC       respiratory epithelia (PubMed:30471717, PubMed:30471718). Produces
CC       force towards the minus ends of microtubules. Dynein has ATPase
CC       activity; the force-producing power stroke is thought to occur on
CC       release of ADP. {ECO:0000269|PubMed:30471717,
CC       ECO:0000269|PubMed:30471718}.
CC   -!- SUBUNIT: Consists of at least two heavy chains and a number of
CC       intermediate and light chains. Interacts with ODAD1 (PubMed:30471718).
CC       {ECO:0000269|PubMed:30471718}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, cilium axoneme
CC       {ECO:0000269|PubMed:30471717, ECO:0000269|PubMed:30471718,
CC       ECO:0000269|PubMed:31178125}. Note=Found in the distal portion of
CC       ciliary axoneme. {ECO:0000269|PubMed:30471717,
CC       ECO:0000269|PubMed:30471718}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NYC9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NYC9-2; Sequence=VSP_035285;
CC       Name=3;
CC         IsoId=Q9NYC9-3; Sequence=VSP_043443;
CC   -!- TISSUE SPECIFICITY: Expressed in upper and lower respiratory airway
CC       epithelia (at protein level). Not detected in spermatozoa (at protein
CC       level) (PubMed:31178125). {ECO:0000269|PubMed:30471717,
CC       ECO:0000269|PubMed:31178125}.
CC   -!- DOMAIN: Dynein heavy chains probably consist of an N-terminal stem
CC       (which binds cargo and interacts with other dynein components), and the
CC       head or motor domain. The motor contains six tandemly-linked AAA
CC       domains in the head, which form a ring. A stalk-like structure (formed
CC       by two of the coiled coil domains) protrudes between AAA 4 and AAA 5
CC       and terminates in a microtubule-binding site. A seventh domain may also
CC       contribute to this ring; it is not clear whether the N-terminus or the
CC       C-terminus forms this extra domain. There are four well-conserved and
CC       two non-conserved ATPase sites, one per AAA domain. Probably only one
CC       of these (within AAA 1) actually hydrolyzes ATP, the others may serve a
CC       regulatory function.
CC   -!- DISEASE: Ciliary dyskinesia, primary, 40 (CILD40) [MIM:618300]: A form
CC       of primary ciliary dyskinesia, a disorder characterized by
CC       abnormalities of motile cilia. Respiratory infections leading to
CC       chronic inflammation and bronchiectasis are recurrent, due to defects
CC       in the respiratory cilia. Some patients exhibit randomization of left-
CC       right body asymmetry and situs inversus. Primary ciliary dyskinesia
CC       associated with situs inversus is referred to as Kartagener syndrome.
CC       CILD40 inheritance is autosomal recessive.
CC       {ECO:0000269|PubMed:30471717, ECO:0000269|PubMed:30471718}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the dynein heavy chain family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF257737; AAF69004.1; -; mRNA.
DR   EMBL; AJ404468; CAB94756.1; -; mRNA.
DR   EMBL; AC005209; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005410; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005701; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC128421; AAI28422.1; -; mRNA.
DR   EMBL; AB002355; BAA21573.2; -; mRNA.
DR   EMBL; AJ132088; CAA10561.1; -; mRNA.
DR   CCDS; CCDS11160.1; -. [Q9NYC9-1]
DR   CCDS; CCDS11161.1; -. [Q9NYC9-3]
DR   RefSeq; NP_001363.2; NM_001372.3. [Q9NYC9-1]
DR   RefSeq; NP_004653.2; NM_004662.2. [Q9NYC9-3]
DR   SMR; Q9NYC9; -.
DR   BioGRID; 108109; 10.
DR   IntAct; Q9NYC9; 1.
DR   STRING; 9606.ENSP00000262442; -.
DR   GlyGen; Q9NYC9; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9NYC9; -.
DR   PhosphoSitePlus; Q9NYC9; -.
DR   BioMuta; DNAH9; -.
DR   DMDM; 311033454; -.
DR   EPD; Q9NYC9; -.
DR   jPOST; Q9NYC9; -.
DR   MassIVE; Q9NYC9; -.
DR   PaxDb; Q9NYC9; -.
DR   PeptideAtlas; Q9NYC9; -.
DR   ProteomicsDB; 83213; -. [Q9NYC9-1]
DR   ProteomicsDB; 83214; -. [Q9NYC9-2]
DR   ProteomicsDB; 83215; -. [Q9NYC9-3]
DR   Antibodypedia; 12949; 54 antibodies from 14 providers.
DR   Ensembl; ENST00000262442.9; ENSP00000262442.3; ENSG00000007174.18. [Q9NYC9-1]
DR   Ensembl; ENST00000608377.5; ENSP00000476951.1; ENSG00000007174.18. [Q9NYC9-3]
DR   GeneID; 1770; -.
DR   KEGG; hsa:1770; -.
DR   MANE-Select; ENST00000262442.9; ENSP00000262442.3; NM_001372.4; NP_001363.2.
DR   UCSC; uc002gne.3; human. [Q9NYC9-1]
DR   AGR; HGNC:2953; -.
DR   CTD; 1770; -.
DR   DisGeNET; 1770; -.
DR   GeneCards; DNAH9; -.
DR   HGNC; HGNC:2953; DNAH9.
DR   HPA; ENSG00000007174; Group enriched (brain, choroid plexus, fallopian tube).
DR   MalaCards; DNAH9; -.
DR   MIM; 603330; gene.
DR   MIM; 618300; phenotype.
DR   neXtProt; NX_Q9NYC9; -.
DR   OpenTargets; ENSG00000007174; -.
DR   Orphanet; 244; Primary ciliary dyskinesia.
DR   Orphanet; 157769; Situs ambiguus.
DR   Orphanet; 101063; Situs inversus totalis.
DR   PharmGKB; PA27406; -.
DR   VEuPathDB; HostDB:ENSG00000007174; -.
DR   eggNOG; KOG3595; Eukaryota.
DR   GeneTree; ENSGT00940000159717; -.
DR   HOGENOM; CLU_000038_9_1_1; -.
DR   InParanoid; Q9NYC9; -.
DR   OMA; ITMDAHG; -.
DR   OrthoDB; 166463at2759; -.
DR   PhylomeDB; Q9NYC9; -.
DR   TreeFam; TF316836; -.
DR   PathwayCommons; Q9NYC9; -.
DR   SignaLink; Q9NYC9; -.
DR   BioGRID-ORCS; 1770; 5 hits in 1144 CRISPR screens.
DR   ChiTaRS; DNAH9; human.
DR   GeneWiki; DNAH9; -.
DR   GenomeRNAi; 1770; -.
DR   Pharos; Q9NYC9; Tdark.
DR   PRO; PR:Q9NYC9; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q9NYC9; protein.
DR   Bgee; ENSG00000007174; Expressed in right uterine tube and 126 other tissues.
DR   ExpressionAtlas; Q9NYC9; baseline and differential.
DR   Genevisible; Q9NYC9; HS.
DR   GO; GO:0097729; C:9+2 motile cilium; IDA:GO_Central.
DR   GO; GO:0005930; C:axoneme; IDA:UniProtKB.
DR   GO; GO:0120135; C:distal portion of axoneme; IDA:UniProtKB.
DR   GO; GO:0030286; C:dynein complex; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; IEA:GOC.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0031514; C:motile cilium; IDA:UniProtKB.
DR   GO; GO:0036157; C:outer dynein arm; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045505; F:dynein intermediate chain binding; IEA:InterPro.
DR   GO; GO:0051959; F:dynein light intermediate chain binding; IEA:InterPro.
DR   GO; GO:0008569; F:minus-end-directed microtubule motor activity; IBA:GO_Central.
DR   GO; GO:0030030; P:cell projection organization; IEA:UniProtKB-KW.
DR   GO; GO:0090660; P:cerebrospinal fluid circulation; IEA:Ensembl.
DR   GO; GO:0003341; P:cilium movement; IMP:UniProtKB.
DR   GO; GO:0051649; P:establishment of localization in cell; IEA:Ensembl.
DR   GO; GO:0120197; P:mucociliary clearance; IEA:Ensembl.
DR   Gene3D; 1.10.287.2620; -; 1.
DR   Gene3D; 1.10.472.130; -; 1.
DR   Gene3D; 1.10.8.1220; -; 1.
DR   Gene3D; 1.10.8.710; -; 1.
DR   Gene3D; 1.20.1270.280; -; 1.
DR   Gene3D; 1.20.58.1120; -; 1.
DR   Gene3D; 1.20.920.20; -; 1.
DR   Gene3D; 1.20.920.30; -; 1.
DR   Gene3D; 3.10.490.20; -; 1.
DR   Gene3D; 6.10.140.1060; -; 1.
DR   Gene3D; 1.20.140.100; Dynein heavy chain, N-terminal domain 2; 1.
DR   Gene3D; 3.20.180.20; Dynein heavy chain, N-terminal domain 2; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 5.
DR   Gene3D; 1.10.8.720; Region D6 of dynein motor; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR035699; AAA_6.
DR   InterPro; IPR035706; AAA_9.
DR   InterPro; IPR041658; AAA_lid_11.
DR   InterPro; IPR042219; AAA_lid_11_sf.
DR   InterPro; IPR026983; DHC_fam.
DR   InterPro; IPR041589; DNAH3_AAA_lid_1.
DR   InterPro; IPR042222; Dynein_2_N.
DR   InterPro; IPR043157; Dynein_AAA1S.
DR   InterPro; IPR041466; Dynein_AAA5_ext.
DR   InterPro; IPR041228; Dynein_C.
DR   InterPro; IPR043160; Dynein_C_barrel.
DR   InterPro; IPR024743; Dynein_HC_stalk.
DR   InterPro; IPR024317; Dynein_heavy_chain_D4_dom.
DR   InterPro; IPR004273; Dynein_heavy_D6_P-loop.
DR   InterPro; IPR013602; Dynein_heavy_linker.
DR   InterPro; IPR013594; Dynein_heavy_tail.
DR   InterPro; IPR042228; Dynein_linker_3.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR46532:SF13; DYNEIN AXONEMAL HEAVY CHAIN 5; 1.
DR   PANTHER; PTHR46532; MALE FERTILITY FACTOR KL5; 1.
DR   Pfam; PF12774; AAA_6; 1.
DR   Pfam; PF12775; AAA_7; 1.
DR   Pfam; PF12780; AAA_8; 1.
DR   Pfam; PF12781; AAA_9; 1.
DR   Pfam; PF17857; AAA_lid_1; 1.
DR   Pfam; PF18198; AAA_lid_11; 1.
DR   Pfam; PF08385; DHC_N1; 1.
DR   Pfam; PF08393; DHC_N2; 1.
DR   Pfam; PF17852; Dynein_AAA_lid; 1.
DR   Pfam; PF18199; Dynein_C; 1.
DR   Pfam; PF03028; Dynein_heavy; 1.
DR   Pfam; PF12777; MT; 1.
DR   SMART; SM00382; AAA; 4.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell projection; Ciliopathy; Cilium;
KW   Cilium biogenesis/degradation; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Disease variant; Dynein; Kartagener syndrome; Microtubule; Motor protein;
KW   Nucleotide-binding; Primary ciliary dyskinesia; Reference proteome; Repeat.
FT   CHAIN           1..4486
FT                   /note="Dynein axonemal heavy chain 9"
FT                   /id="PRO_0000114632"
FT   REGION          1..1831
FT                   /note="Stem"
FT                   /evidence="ECO:0000250"
FT   REGION          1832..2053
FT                   /note="AAA 1"
FT                   /evidence="ECO:0000250"
FT   REGION          2113..2334
FT                   /note="AAA 2"
FT                   /evidence="ECO:0000250"
FT   REGION          2440..2688
FT                   /note="AAA 3"
FT                   /evidence="ECO:0000250"
FT   REGION          2787..3036
FT                   /note="AAA 4"
FT                   /evidence="ECO:0000250"
FT   REGION          3051..3341
FT                   /note="Stalk"
FT                   /evidence="ECO:0000250"
FT   REGION          3429..3656
FT                   /note="AAA 5"
FT                   /evidence="ECO:0000250"
FT   REGION          3866..4092
FT                   /note="AAA 6"
FT                   /evidence="ECO:0000250"
FT   COILED          381..410
FT                   /evidence="ECO:0000255"
FT   COILED          504..529
FT                   /evidence="ECO:0000255"
FT   COILED          639..662
FT                   /evidence="ECO:0000255"
FT   COILED          752..823
FT                   /evidence="ECO:0000255"
FT   COILED          1326..1355
FT                   /evidence="ECO:0000255"
FT   COILED          3051..3154
FT                   /evidence="ECO:0000255"
FT   COILED          3285..3341
FT                   /evidence="ECO:0000255"
FT   COILED          3640..3675
FT                   /evidence="ECO:0000255"
FT   BINDING         1870..1877
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   BINDING         2151..2158
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   BINDING         2478..2485
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   BINDING         2825..2832
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..3688
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043443"
FT   VAR_SEQ         3961..4036
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9205841"
FT                   /id="VSP_035285"
FT   VARIANT         151
FT                   /note="R -> H (in dbSNP:rs17599639)"
FT                   /id="VAR_046312"
FT   VARIANT         445
FT                   /note="Q -> R (in dbSNP:rs9892256)"
FT                   /evidence="ECO:0000269|PubMed:11247663, ECO:0000269|Ref.1"
FT                   /id="VAR_046313"
FT   VARIANT         666..4486
FT                   /note="Missing (in CILD40)"
FT                   /evidence="ECO:0000269|PubMed:30471718"
FT                   /id="VAR_081802"
FT   VARIANT         771
FT                   /note="R -> L (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036214"
FT   VARIANT         842
FT                   /note="R -> W (in dbSNP:rs16945138)"
FT                   /id="VAR_046314"
FT   VARIANT         1158
FT                   /note="R -> W (in dbSNP:rs8070501)"
FT                   /id="VAR_046315"
FT   VARIANT         1221
FT                   /note="T -> A (in dbSNP:rs9916482)"
FT                   /id="VAR_046316"
FT   VARIANT         1674
FT                   /note="G -> R (in CILD40; unknown pathological
FT                   significance; dbSNP:rs140721719)"
FT                   /evidence="ECO:0000269|PubMed:30471718"
FT                   /id="VAR_081803"
FT   VARIANT         1881
FT                   /note="K -> E (in CILD40; associated in cis with H-2965; no
FT                   protein detected by Western blot when associated with
FT                   H-2965; loss of localization to cilium axonema associated
FT                   with H-2965; dbSNP:rs1567747142)"
FT                   /evidence="ECO:0000269|PubMed:30471717"
FT                   /id="VAR_081804"
FT   VARIANT         2087
FT                   /note="M -> V (in dbSNP:rs9892290)"
FT                   /id="VAR_046317"
FT   VARIANT         2195
FT                   /note="N -> S (in dbSNP:rs3744581)"
FT                   /id="VAR_046318"
FT   VARIANT         2438
FT                   /note="Q -> H (in dbSNP:rs2277658)"
FT                   /id="VAR_046319"
FT   VARIANT         2653
FT                   /note="D -> H (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036215"
FT   VARIANT         2751..4486
FT                   /note="Missing (in CILD40; loss of localization to cilium
FT                   axonema)"
FT                   /evidence="ECO:0000269|PubMed:30471718"
FT                   /id="VAR_081805"
FT   VARIANT         2961
FT                   /note="K -> R (in dbSNP:rs11870983)"
FT                   /id="VAR_046320"
FT   VARIANT         2965
FT                   /note="R -> H (in CILD40; associated in cis with E-1881; no
FT                   protein detected by Western blot when associated with
FT                   E-1881; loss of localization to cilium axonema when
FT                   associated with E-1881; dbSNP:rs375908701)"
FT                   /evidence="ECO:0000269|PubMed:30471717"
FT                   /id="VAR_081806"
FT   VARIANT         2968
FT                   /note="K -> N (in dbSNP:rs11871037)"
FT                   /id="VAR_046321"
FT   VARIANT         3398
FT                   /note="R -> L (in CILD40; dbSNP:rs763238622)"
FT                   /evidence="ECO:0000269|PubMed:30471717"
FT                   /id="VAR_081807"
FT   VARIANT         3664
FT                   /note="T -> N (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs138874996)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036216"
FT   VARIANT         3726
FT                   /note="R -> Q (in dbSNP:rs16945431)"
FT                   /id="VAR_046322"
FT   VARIANT         3726
FT                   /note="R -> W (in dbSNP:rs3760436)"
FT                   /id="VAR_046323"
FT   VARIANT         3889..4486
FT                   /note="Missing (in CILD40)"
FT                   /evidence="ECO:0000269|PubMed:30471718"
FT                   /id="VAR_081808"
FT   VARIANT         4036
FT                   /note="D -> N (in dbSNP:rs17612861)"
FT                   /id="VAR_046324"
FT   VARIANT         4123
FT                   /note="D -> N (in CILD40; loss of localization to cilium
FT                   axonema; dbSNP:rs1267599270)"
FT                   /evidence="ECO:0000269|PubMed:30471717"
FT                   /id="VAR_081809"
FT   VARIANT         4374
FT                   /note="M -> I (in dbSNP:rs1990236)"
FT                   /evidence="ECO:0000269|Ref.1"
FT                   /id="VAR_046325"
FT   VARIANT         4443
FT                   /note="R -> C (in dbSNP:rs9913494)"
FT                   /id="VAR_046326"
FT   VARIANT         4462
FT                   /note="W -> R (in dbSNP:rs8074656)"
FT                   /id="VAR_046327"
FT   CONFLICT        2216
FT                   /note="I -> T (in Ref. 5; BAA21573)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2505
FT                   /note="V -> L (in Ref. 1; AAF69004)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3678
FT                   /note="A -> T (in Ref. 1; AAF69004)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   4486 AA;  511877 MW;  27EB53C39FA3A293 CRC64;
     MRLAEERAAL AAENADGEPG ADRRLRLLGT YVAMSLRPAA GAWERCAGSA EAEQLLQAFL
     GRDAAEGPRP LLVVRPGPRG LAIRPGLEVG PESGLAGAKA LFFLRTGPEP PGPDSFRGAV
     VCGDLPAAPL EHLAALFSEV VLPVLANEKN RLNWPHMICE DVRRHAHSLQ CDLSVILEQV
     KGKTLLPLPA GSEKMEFADS KSETVLDSID KSVIYAIESA VIKWSYQVQV VLKRESSQPL
     LQGENPTPKV ELEFWKSRYE DLKYIYNQLR TITVRGMAKL LDKLQSSYFP AFKAMYRDVV
     AALAEAQDIH VHLIPLQRHL EALENAEFPE VKPQLRPLLH VVCLIWATCK SYRSPGRLTV
     LLQEICNLLI QQASNYLSPE DLLRSEVEES QRKLQVVSDT LSFFKQEFQD RRENLHTYFK
     ENQEVKEWDF QSSLVFVRLD GFLGQLHVVE GLLKTALDFH KLGKVEFSGV RGNALSQQVQ
     QMHEEFQEMY RLLSGSSSDC LYLQSTDFEN DVSEFNQKVE DLDRRLGTIF IQAFDDAPGL
     EHAFKLLDIA GNLLERPLVA RDTSDKYLVL IQMFNKDLDA VRMIYSQHVQ EEAELGFSPV
     HKNMPTVAGG LRWAQELRQR IQGPFSNFGR ITHPCMESAE GKRMQQKYED MLSLLEKYET
     RLYEDWCRTV SEKSQYNLSQ PLLKRDPETK EITINFNPQL ISVLKEMSYL EPREMKHMPE
     TAAAMFSSRD FYRQLVANLE LMANWYNKVM KTLLEVEFPL VEEELQNIDL RLRAAEETLN
     WKTEGICDYV TEITSSIHDL EQRIQKTKDN VEEIQNIMKT WVTPIFKTKD GKRESLLSLD
     DRHDRMEKYY NLIKESGLKI HALVQENLGL FSADPTSNIW KTYVNSIDNL LLNGFFLAIE
     CSLKYLLENT ECKAGLTPIF EAQLSLAIPE LVFYPSLESG VKGGFCDIVE GLITSIFRIP
     SLVPRLSPQN GSPHYQVDLD GIPDLANMRR TLMERVQRMM GLCCGYQSTF SQYSYLYVED
     RKEVLGQFLL YGHILTPEEI EDHVEDGIPE NPPLLSQFKV QIDSYETLYE EVCRLEPIKV
     FDGWMKIDIR PFKASLLNII KRWSLLFKQH LVDHVTHSLA NLDAFIKKSE SGLLKKVEKG
     DFQGLVEIMG HLMAVKERQS NTDEMFEPLK QTIELLKTYE QELPETVFKQ LEELPEKWNN
     IKKVAITVKQ QVAPLQANEV TLLRQRCTAF DAEQQQFWEQ FHKEAPFRFD SIHPHQMLDA
     RHIEIQQMES TMASISESAS LFEVNVPDYK QLRQCRKEVC QLKELWDTIG MVTSSIHAWE
     TTPWRNINVE AMELECKQFA RHIRNLDKEV RAWDAFTGLE STVWNTLSSL RAVAELQNPA
     IRERHWRQLM QATGVSFTMD QDTTLAHLLQ LQLHHYEDEV RGIVDKAAKE MGMEKTLKEL
     QTTWAGMEFQ YEPHPRTNVP LLCSDEDLIE VLEDNQVQLQ NLVMSKYVAF FLEEVSGWQK
     KLSTVDAVIS IWFEVQRTWT HLESIFTGSE DIRAQLPQDS KRFEGIDIDF KELAYDAQKI
     PNVVQTTNKP GLYEKLEDIQ GRLCLCEKAL AEYLDTKRLA FPRFYFLSSS DLLDILSNGT
     APQQVQRHLS KLFDNMAKMR FQLDASGEPT KTSLGMYSKE EEYVAFSEPC DCSGQVEIWL
     NHVLGHMKAT VRHEMTEGVT AYEEKPREQW LFDHPAQVAL TCTQIWWTTE VGMAFARLEE
     GYESAMKDYY KKQVAQLKTL ITMLIGQLSK GDRQKIMTIC TIDVHARDVV AKMIAQKVDN
     AQAFLWLSQL RHRWDDEVKH CFANICDAQF LYSYEYLGNT PRLVITPLTD RCYITLTQSL
     HLTMSGAPAG PAGTGKTETT KDLGRALGIL VYVFNCSEQM DYKSCGNIYK GLAQTGAWGC
     FDEFNRISVE VLSVVAVQVK SIQDAIRDKK QWFSFLGEEI SLNPSVGIFI TMNPGYAGRT
     ELPENLKSLF RPCAMVVPDF ELICEIMLVA EGFIEAQSLA RKFITLYQLC KELLSKQDHY
     DWGLRAIKSV LVVAGSLKRG DPDRPEDQVL MRSLRDFNIP KIVTDDMPIF MGLIGDLFPA
     LDVPRRRDPN FEALVRKAIV DLKLQAEDNF VLKVVQLEEL LAVRHSVFVV GGAGTGKSQV
     LRSLHKTYQI MKRRPVWTDL NPKAVTNDEL FGIINPATGE WKDGLFSSIM RELANITHDG
     PKWILLDGDI DPMWIESLNT VMDDNKVLTL ASNERIPLNP TMKLLFEISH LRTATPATVS
     RAGILYINPA DLGWNPPVSS WIEKREIQTE RANLTILFDK YLPTCLDTLR TRFKKIIPIP
     EQSMVQMVCH LLECLLTTED IPADCPKEIY EHYFVFAAIW AFGGAMVQDQ LVDYRAEFSK
     WWLTEFKTVK FPSQGTIFDY YIDPETKKFE PWSKLVPQFE FDPEMPLQAC LVHTSETIRV
     CYFMERLMAR QRPVMLVGTA GTGKSVLVGA KLASLDPEAY LVKNVPFNYY TTSAMLQAVL
     EKPLEKKAGR NYGPPGNKKL IYFIDDMNMP EVDAYGTVQP HTIIRQHLDY GHWYDRSKLS
     LKEITNVQYV SCMNPTAGSF TINPRLQRHF SVFVLSFPGA DALSSIYSII LTQHLKLGNF
     PASLQKSIPP LIDLALAFHQ KIATTFLPTG IKFHYIFNLR DFANIFQGIL FSSVECVKST
     WDLIRLYLHE SNRVYRDKMV EEKDFDLFDK IQTEVLKKTF DDIEDPVEQT QSPNLYCHFA
     NGIGEPKYMP VQSWELLTQT LVEALENHNE VNTVMDLVLF EDAMRHVCHI NRILESPRGN
     ALLVGVGGSG KQSLTRLAAF ISSMDVFQIT LRKGYQIQDF KMDLASLCLK AGVKNLNTVF
     LMTDAQVADE RFLVLINDLL ASGEIPDLYS DDEVENIISN VRNEVKSQGL VDNRENCWKF
     FIDRIRRQLK VTLCFSPVGN KLRVRSRKFP AIVNCTAIHW FHEWPQQALE SVSLRFLQNT
     EGIEPTVKQS ISKFMAFVHT SVNQTSQSYL SNEQRYNYTT PKSFLEFIRL YQSLLHRHRK
     ELKCKTERLE NGLLKLHSTS AQVDDLKAKL AAQEVELKQK NEDADKLIQV VGVETDKVSR
     EKAMADEEEQ KVAVIMLEVK QKQKDCEEDL AKAEPALTAA QAALNTLNKT NLTELKSFGS
     PPLAVSNVSA AVMVLMAPRG RVPKDRSWKA AKVTMAKVDG FLDSLINFNK ENIHENCLKA
     IRPYLQDPEF NPEFVATKSY AAAGLCSWVI NIVRFYEVFC DVEPKRQALN KATADLTAAQ
     EKLAAIKAKI AHLNENLAKL TARFEKATAD KLKCQQEAEV TAVTISLANR LVGGLASENV
     RWADAVQNFK QQERTLCGDI LLITAFISYL GFFTKKYRQS LLDRTWRPYL SQLKTPIPVT
     PALDPLRMLM DDADVAAWQN EGLPADRMSV ENATILINCE RWPLMVDPQL QGIKWIKNKY
     GEDLRVTQIG QKGYLQIIEQ ALEAGAVVLI ENLEESIDPV LGPLLGREVI KKGRFIKIGD
     KECEYNPKFR LILHTKLANP HYQPELQAQA TLINFTVTRD GLEDQLLAAV VSMERPDLEQ
     LKSDLTKQQN GFKITLKTLE DSLLSRLSSA SGNFLGETVL VENLEITKQT AAEVEKKVQE
     AKVTEVKINE AREHYRPAAA RASLLYFIMN DLSKIHPMYQ FSLKAFSIVF QKAVERAAPD
     ESLRERVANL IDSITFSVYQ YTIRGLFECD KLTYLAQLTF QILLMNREVN AVELDFLLRS
     PVQTGTASPV EFLSHQAWGA VKVLSSMEEF SNLDRDIEGS AKSWKKFVES ECPEKEKLPQ
     EWKNKTALQR LCMLRAMRPD RMTYALRDFV EEKLGSKYVV GRALDFATSF EESGPATPMF
     FILSPGVDPL KDVESQGRKL GYTFNNQNFH NVSLGQGQEV VAEAALDLAA KKGHWVILQN
     IHLVAKWLST LEKKLEEHSE NSHPEFRVFM SAEPAPSPEG HIIPQGILEN SIKITNEPPT
     GMHANLHKAL DNFTQDTLEM CSRETEFKSI LFALCYFHAV VAERRKFGPQ GWNRSYPFNT
     GDLTISVNVL YNFLEANAKV PYDDLRYLFG EIMYGGHITD DWDRRLCRTY LGEFIRPEML
     EGELSLAPGF PLPGNMDYNG YHQYIDAELP PESPYLYGLH PNAEIGFLTQ TSEKLFRTVL
     ELQPRDSQAR DGAGATREEK VKALLEEILE RVTDEFNIPE LMAKVEERTP YIVVAFQECG
     RMNILTREIQ RSLRELELGL KGELTMTSHM ENLQNALYFD MVPESWARRA YPSTAGLAAW
     FPDLLNRIKE LEAWTGDFTM PSTVWLTGFF NPQSFLTAIM QSTARKNEWP LDQMALQCDM
     TKKNREEFRS PPREGAYIHG LFMEGACWDT QAGIITEAKL KDLTPPMPVM FIKAIPADKQ
     DCRSVYSCPV YKTSQRGPTY VWTFNLKTKE NPSKWVLAGV ALLLQI
//
